EFFECTIVE AUGUST 23, 2004

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                          WASHINGTON, D.C. 20549

                                FORM 8-K

                                 CURRENT REPORT
     Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934



Date of Report (Date of earliest event reported)    March 29, 2005



                           BIOPHAN TECHNOLOGIES, INC.
                 --------------------------------------------
             (Exact name of registrant as specified in its charter)



         NEVADA                       0-26057               82-0507874
-----------------------------      -------------            -----------
(State or other jurisdiction       (Commission           (I.R.S. Employer
         of incorporation)          File Number)         Identification No.)


      150 LUCIUS GORDON DRIVE,  SUITE 215
            WEST HENRIETTA, NEW YORK                     14586
      ---------------------------------------          ---------
      (Address of principal executive offices)         (Zip code)


                             (585) 214-2441
                         -------------------------
                         (Registrant's telephone number)

<PAGE>


Item 7.01 Regulation FD Disclosure

On March 29, 2005, in an audio interview with SmallcapInsights.com, Company CEO
Michael Weiner explained the importance of the Company's recent issued patents
and patent applications. See attached Exhibit 99.1 for a complete transcript of
the interview.

                                       2
<PAGE>

                                   SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.


                                           BIOPHAN TECHNOLOGIES, INC.
                                           --------------------------
                                           (Registrant)

Date: 3/30/05                              /S/ Robert J. Wood
                                           ---------------------------------
                                           (Signature)

                                           Robert J. Wood
                                           CFO, Treasurer, Secretary
                                           (Principal Financial Officer)
{"company-data": {"conformed-name": "BIOPHAN TECHNOLOGIES INC", "cik": "0001084000", "assigned-sic": "3841", "irs-number": "820507874", "state-of-incorporation": "NV", "fiscal-year-end": "0228"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-26057", "film-number": "05711661"}, "business-address": {"street1": "150 LUCIUS GORDON DR", "street2": "STE 215", "city": "WEST HENRIETTA", "state": "NY", "zip": "14586", "phone": "5852142441"}, "mail-address": {"street1": "150 LUCIUS GORDON DR", "street2": "STE 215", "city": "WEST HENRIETTA", "state": "NY", "zip": "14586"}, "former-company": {"former-conformed-name": "GREATBIO TECHNOLOGIES INC", "date-changed": "20001215"}}
EFFECTIVE AUGUST 23, 2004

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                          WASHINGTON, D.C. 20549

                                FORM 8-K

                                 CURRENT REPORT
     Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)    March 29, 2005

                           BIOPHAN TECHNOLOGIES, INC.
                 --------------------------------------------
             (Exact name of registrant as specified in its charter)

         NEVADA                       0-26057               82-0507874
-----------------------------      -------------            -----------
(State or other jurisdiction       (Commission           (I.R.S. Employer
         of incorporation)          File Number)         Identification No.)

      150 LUCIUS GORDON DRIVE,  SUITE 215
            WEST HENRIETTA, NEW YORK                     14586
      ---------------------------------------          ---------
      (Address of principal executive offices)         (Zip code)

                             (585) 214-2441
                         -------------------------
                         (Registrant's telephone number)
Item 7.01 Regulation FD Disclosure

On March 29, 2005, in an audio interview with SmallcapInsights.com, Company CEO
Michael Weiner explained the importance of the Company's recent issued patents
and patent applications. See attached Exhibit 99.1 for a complete transcript of
the interview.

                                       2
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                           BIOPHAN TECHNOLOGIES, INC.
                                           --------------------------
                                           (Registrant)

Date: 3/30/05                              /S/ Robert J. Wood
                                           ---------------------------------
                                           (Signature)

                                           Robert J. Wood
                                           CFO, Treasurer, Secretary
                                           (Principal Financial Officer)